What happened?
WHO is launching two new guidelines on integrated management of obesity in children and adolescents. The documents set out how health systems and health workers can deliver timely, evidence‑based, people‑centred care across prevention, assessment and treatment. The guidance complements WHO recommendations for adults to cover the life course.
Why does it matter?
WHO says the guidelines fill a gap in global guidance as childhood and adolescent overweight and obesity have risen sharply. In 2024 an estimated 400 million 5–19‑year‑olds were overweight, including 170 million with obesity. The recommendations aim to support consistent, evidence‑based services for this growing group.
How to interpret the evidence
The guidance is global and aimed at health systems and clinicians; applicability in the EU or Malta depends on national policy, resources and regulatory frameworks. The documents provide a framework for service organisation and clinical pathways but do not guarantee availability of specific treatments or technologies locally.
What remains uncertain?
This launch is not individual medical advice, a new drug approval, or an indication that all recommended services are immediately available in every country. Clinicians should combine the guidance with local regulations, resources and individual clinical judgement when managing patients.
Medical News provides general health education. Individual treatment decisions depend on your circumstances and the advice of your clinical team.
This summary was prepared with AI assistance and checked automatically against the linked primary source. It has not been individually reviewed by a clinician.